K M C Speciality Hospitals (India) Limited
BSE: KMCSHIL · Hospital
Snapshot
Unlock K M C Speciality Hospitals (India) Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
KMC Speciality Hospitals (India) Ltd. is a healthcare provider based in Trichy, offering a comprehensive range of medical services and advanced diagnostic facilities. The company operates as a multi-speciality hospital chain providing critical care, laboratory services, and imaging diagnostics.
Business Model
The company generates revenue primarily through the provision of inpatient and outpatient medical services, diagnostic testing, and specialised surgical procedures. It leverages its infrastructure and medical equipment to offer a wide spectrum of healthcare support to the local population.
Growth Outlook
Growth is expected to be driven by the increasing demand for specialised healthcare services and the continuous upgrading of diagnostic and medical infrastructure. The company focuses on maintaining its service standards to capture a larger share of the regional healthcare market.
Key Risks
- Regulatory Risk. Changes in government healthcare policies or price caps on medical procedures could adversely impact profit margins.
- Operational Risk. The hospital relies heavily on the availability of skilled medical professionals and the maintenance of sophisticated diagnostic equipment.
- Competitive Pressure. The healthcare sector in India is highly fragmented, with increasing competition from both large hospital chains and local nursing homes.
Start your research today
Unlock AI insights, financials, peers and live data on K M C Speciality Hospitals (India) Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹331 Cr
TTM · standalone
NET PROFIT
₹56 Cr
TTM · standalone
EPS
₹3.42
TTM · standalone
RETURN ON EQUITY
29.8%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
31.1%
TTM · standalone
P/E
50.3×
Q1 FY27 · standalone
EV/EBITDA
25.1x
Q1 FY27 · standalone
EBITDA MARGIN
32.0%
TTM · standalone
NET PROFIT MARGIN
18.1%
Q1 FY27 · standalone
DEBT TO EQUITY
0.3x
Q1 FY27 · standalone
Peers · Hospital
| Company | Mkt Cap | P/E (TTM) | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
K M C Speciality Hospitals (India) LimitedKMCSHIL | ₹2,645 Cr | 50.3× | 25.14 | 35.1% | 32.0% | 29.8% | 31.1% | +159.8% |
Indraprastha Medical Corporation Ltd.INDRAMEDCO | ₹3,434 Cr | 16.5× | 11.29 | 10.9% | 19.9% | 28.1% | 34.6% | -25.7% |
Dr Agarwals Eye Hospital LimitedDRAGARWQ | ₹2,514 Cr | 32.5× | 16.34 | 20.0% | 31.9% | 27.4% | 18.9% | +3.9% |
Shalby Ltd.SHALBY | ₹1,573 Cr | 38.2× | 12.30 | 6.5% | 14.5% | 3.8% | 7.8% | -49.4% |
Gujarat Kidney And Super Speciality LimitedGKSL | ₹1,401 Cr | — | — | — | 33.0% | — | — | — |
Gpt Healthcare Ltd.GPTHEALTH | ₹1,325 Cr | 26.3× | 13.73 | 18.1% | 19.8% | 18.3% | 20.0% | +2.6% |
As of Q1 FY27
Financials
K M C Speciality Hospitals (India) Limited
BSE: KMCSHIL · Hospital
Snapshot
Unlock K M C Speciality Hospitals (India) Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
KMC Speciality Hospitals (India) Ltd. is a healthcare provider based in Trichy, offering a comprehensive range of medical services and advanced diagnostic facilities. The company operates as a multi-speciality hospital chain providing critical care, laboratory services, and imaging diagnostics.
Business Model
The company generates revenue primarily through the provision of inpatient and outpatient medical services, diagnostic testing, and specialised surgical procedures. It leverages its infrastructure and medical equipment to offer a wide spectrum of healthcare support to the local population.
Growth Outlook
Growth is expected to be driven by the increasing demand for specialised healthcare services and the continuous upgrading of diagnostic and medical infrastructure. The company focuses on maintaining its service standards to capture a larger share of the regional healthcare market.
Key Risks
- Regulatory Risk. Changes in government healthcare policies or price caps on medical procedures could adversely impact profit margins.
- Operational Risk. The hospital relies heavily on the availability of skilled medical professionals and the maintenance of sophisticated diagnostic equipment.
- Competitive Pressure. The healthcare sector in India is highly fragmented, with increasing competition from both large hospital chains and local nursing homes.
Start your research today
Unlock AI insights, financials, peers and live data on K M C Speciality Hospitals (India) Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹331 Cr
TTM · standalone
NET PROFIT
₹56 Cr
TTM · standalone
EPS
₹3.42
TTM · standalone
RETURN ON EQUITY
29.8%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
31.1%
TTM · standalone
P/E
50.3x
Q1 FY27 · standalone
EV/EBITDA
25.1x
Q1 FY27 · standalone
EBITDA MARGIN
32.0%
TTM · standalone
NET PROFIT MARGIN
18.1%
Q1 FY27 · standalone
DEBT TO EQUITY
0.3x
Q1 FY27 · standalone
Peers · Hospital
As of Q1 FY27